2023
DOI: 10.1152/physiol.2023.38.s1.5733896
|View full text |Cite
|
Sign up to set email alerts
|

Acellular hemoglobin impairs calcium release and contractility in cardiomyocytes from healthy animals

Abstract: Hemoglobin (Hb)-based oxygen (O2) carriers (HBOC) have been proposed as an alternative for blood transfusion. Phase III clinical trials of previous HBOC generations presented issues, such as vasoconstriction and myocardial infarction, that were not detected in pre-clinical trials. These problems have been attributed to extravasation of the low molecular weight (LMW) Hb species, nitric oxide (NO) scavenging and O2 oversupply to the vasculature. However, the mechanisms responsible for the cardiac toxicity of HBO… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles